BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Medivir AB 

Lunastigen 7

Huddinge    141 44  Sweden
Phone: 46-8-608-3100 Fax: 46-8-608-3199


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical


Collaborations

GlaxoSmithKline (North Carolina) 

Peptimmune, Inc.  Development agreement for inhibitors of Cathepsin S for autoimmune and allergic diseases.





 Company News
Medivir AB (MVRBF): Optimization Of Capital Structure 10/16/2014 1:53:36 PM
Medivir AB (MVRBF): Phase 2 IMPACT Study Initiated To Evaluate Simeprevir In Combination With Sofosbuvir And Daclatasvir To Treat Genotype 1 And 4 Hepatitis C Patients 10/10/2014 8:33:57 AM
Medivir AB (MVRBF) Capital Markets Meeting on 16 October 2014 10/7/2014 1:28:50 PM
Medivir AB (MVRBF): Interim Report, January – June 2014* 8/21/2014 8:32:57 AM
Ex-Merck & Co., Inc. (MRK) Exec Appointed New President And CEO Of Medivir AB (MVRBF) 8/11/2014 6:15:44 AM
Medivir AB (MVRBF) Licenses Respiratory Syncytial Virus Drug Program From Boehringer Ingelheim Corporation 8/4/2014 11:04:25 AM
Medivir AB (MVRBF): Phase II COSMOS Study Results Published In Lancet On World Hepatitis Day 7/28/2014 8:56:00 AM
Medivir AB (MVRBF): FDA Has Granted Priority Review For OLYSIO® In Combination With Sofosbuvir Supplementary New Drug Application 7/15/2014 8:19:07 AM
Beactica Initiates Drug Discovery Collaboration With Medivir AB (MVRBF) 6/10/2014 11:05:26 AM
Medivir AB (MVRBF) Release: OLYSIO™ Available Soon In All Nordic Countries For The Treatment Of Adults With Hepatitis C Genotype 1 And 4 Infection 6/10/2014 8:56:08 AM
12345678910...